Our analysis revealed that in the case of Glioma and Liver hepatocellular carcinoma patients with high PFKFB4 expression have significantly lower overall survival rates in comparison to patients with low expression of PFKFB4 (Table 1). The gene discussed is PFKFB4; the disease is glioma.